Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Clin Invest ; 51(4): 955-63, 1972 Apr.
Article in English | MEDLINE | ID: mdl-4111367

ABSTRACT

Human sera have been examined for antibodies with specific reactivity for gammaE using the tanned cell hemagglutination test. Cells tanned with three different gammaE myeloma proteins provided a reproducible test system. Inhibition of agglutination reactions by gammaE proteins, but not by gammaG, gammaA, gammaM, or gammaD confirmed the specificity of these reactions. 8.5% of 304 serial serum samples obtained from miscellaneous hospitalized patients showed clear-cut anti-gamma-globulins with specificity for gammaE. In most of these instances no definite clinical history of concomitant allergic disorders could be obtained. 53% of 73 patients with well-established allergic disorders (hay fever, extrinsic asthma) showed serum anti-gamma-globulins with reactivity for gammaE. Some patients studied before and after desensitization to Bermuda grass allergen showed an increase in titer or a conversion from negative to positive reactions for anti-gammaE antibodies following several month courses of progressive desensitization. Gradient and gel filtration studies indicated that anti-gammaE globulins were 19S gammaM in all instances. No clear correlation was noted between quantitative serum gammaE levels and titer of anti-gammaE antibodies.19S serum fractions with anti-gammaE antibody activity did not release histamine from normal human peripheral blood leukocytes, whereas specific rabbit anti-gammaE antisera consistently induced leukocytic histamine release. Moreover, macroglobulin fractions with anti-gammaE activity did not block allergen-specific leukocyte histamine release induced by in vitro leukocyte challenge with allergens such as Bermuda grass and leukocytes from allergic donors. In some instances 19S human serum fractions with anti-gammaE activity appeared to potentiate histamine release when incubated concomitantly with specific allergen and leukocytes from allergic individuals.


Subject(s)
Antibodies, Anti-Idiotypic/analysis , Hypersensitivity/immunology , Immunoglobulin E/antagonists & inhibitors , Immunoglobulins/antagonists & inhibitors , Allergens , Antigen-Antibody Complex , Arthritis, Rheumatoid/immunology , Ascariasis/immunology , Asthma/immunology , Basophils/immunology , Centrifugation, Density Gradient , Desensitization, Immunologic , Eczema/immunology , Hemagglutination Tests , Histamine Release , Humans , Immunochemistry , Immunoglobulin E/analysis , Larva Migrans, Visceral/immunology , Leukocytes/immunology , Lupus Erythematosus, Systemic/immunology , Morphine Dependence/immunology , Rhinitis, Allergic, Seasonal/immunology
3.
J Clin Invest ; 50(7): 1514-24, 1971 Jul.
Article in English | MEDLINE | ID: mdl-5090066

ABSTRACT

42 human sera showing in vitro cytotoxic activity of restricted or broad HL-A specificities with test human lymphocytes were studied for the molecular and immunoglobulin class of cytotoxic antibody using sucrose gradient separations, DEAE-cellulose chromatography, and Sephadex G-200 gel filtration. Sera originated from patients with previous multiple pregnancies (19), multiply transfused patients (8), subacute bacterial endocarditis (4), systemic lupus (2), and human umbilical cord sera (9). In 32 of 42 instances, predominant cytotoxic activity was found in high molecular weight gradient fractions; however, DEAE chromatographic separations revealed cytotoxic activity in initial buffer fractions containing primarily gammaG globulin. Gradient separations of cytotoxic activity within initial gammaG DEAE fractions showed localization of cytotoxicity only in high molecular weight materials. Confirmation of high molecular weight gammaG cytotoxic activity was obtained by resistance to mercaptoethanol treatment, abolition of activity after absorption only with specific anti-gammaG antisera, and by the finding that high molecular weight cytotoxic activity in gradients or gel filtration run at neutral pH 7.4 became 7S when separations were rerun at an acidic pH of 4.0. Such 7S activity again became rapidly sedimenting when the same fractions were again rerun in gradients at neutral pH.19S gammaM cytotoxic activity was documented in a panel of 15 human sera containing anti-"I" cold agglutinins. In this instance the cytotoxic activity appeared to be related to the cold agglutinin antibody since it was mercaptoethanol sensitive and could be demonstrated in monoclonal antibody eluates containing primarily gammaM. No in vitro protection again cytotoxic effect was demonstrated when isolated human 19S anti-gamma-globulins were aded to the lymphocytotoxic assay system. With the exception of cold agglutinins, human cytotoxic antibodies appear to be primarily gammaG producing in vitro lymphocyte killing either as 7S gammaG globulin or as rapidly sedimenting aggregates or complexes of gammaG molecules.


Subject(s)
Antibodies , Lymphocytes/immunology , Anemia, Hemolytic/immunology , Antibody Specificity , Blood Transfusion , Centrifugation, Density Gradient , Chromatography, DEAE-Cellulose , Chromatography, Gel , Cold Temperature , Complement System Proteins , Cryoglobulins , Cytotoxicity Tests, Immunologic , Endocarditis, Subacute Bacterial/immunology , Female , Histocompatibility , Humans , Immunoglobulin G , Immunoglobulin M , Lupus Erythematosus, Systemic/immunology , Molecular Weight , Pregnancy , Umbilical Cord
SELECTION OF CITATIONS
SEARCH DETAIL
...